| Message: | Product Name: Tesamorelin
Alias: Egrifta
CAS: 218949-48-5
MF: C221H366N72O67S
MW: 5135.9
Tesamorelin (INN) (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. It is produced and developed by Theratechnologies, Inc. of Canada.
Tesamorelin is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.
Tesamorelin is used for Reducing excess stomach fat in certain HIV-infected patients.
Tesamorelin is a human growth hormone-releasing factor (GRF) analog. It works by stimulating the pituitary gland to release growth hormone (GH). This causes the breakdown of excess stomach fat.
Do Not Use Tesamorelin If:
you are allergic to any ingredient in tesamorelin or to mannitol
you are pregnant
you have cancer, an underactive pituitary gland, or a pituitary gland tumor
you have had your pituitary gland removed, pituitary gland surgery, radiation treatment of the head, or a head injury
Contact your doctor or health care provider right away if any of these apply to you.
|
my account
